Ji Min Oh

Summary

Country: Korea

Publications

  1. Jeong J, Oh J, Jeong S, Lee S, Lee J, Ahn B. Combination treatment with BRAFV600E inhibitor, vemurafenib, and BH3 mimetic, navitoclax, for BRAF mutant thyroid carcinoma. Thyroid. 2019;: pubmed publisher
    ..Thus, the combination of vemurafenib with navitoclax may be effective in BRAFV600E-positive PTC treatment. ..
  2. Kalimuthu S, Zhu L, Oh J, Lee H, Gangadaran P, Rajendran R, et al. Regulated Mesenchymal Stem Cells Mediated Colon Cancer Therapy Assessed by Reporter Gene Based Optical Imaging. Int J Mol Sci. 2018;19: pubmed publisher
    ..In addition, our results provide an innovative therapeutic approach using the Tet-On system to eradicate tumors by administration of MSC-Tet-TK cells with DOX and GCV. ..
  3. Kalimuthu S, Jeong J, Oh J, Ahn B. Drug Discovery by Molecular Imaging and Monitoring Therapy Response in Lymphoma. Int J Mol Sci. 2017;18: pubmed publisher
    ..Further, we discuss the different molecular imaging modalities for lymphoma therapy and their preclinical and clinical applications. ..